FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH
|
|
|
- CAS号:
- 1821378-64-6
- 英文名:
- FMOC-GLN(TRT)-SER(PSI-ME,MEPRO)-OH
- 英文别名:
- Fmoc-Gln(Trt)-Ser(ψMe,Me Pro)-OH;FMOC-GLN(TRT)-SER(PSI-ME,MEPRO)-OH;Fmoc-GIn(Trt)-Ser[PSI(Me,Me)Pro]-OH;FMOC-GLN(TRT)-SER(PSIME,MEPRO)-OH_1821378-64-6;(9H-Fluoren-9-yl)MethOxy]Carbonyl Gln(Trt)-SerPsi(Me, Me)Pro-OH;(S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid;(4S)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-[(triphenylmethyl)carbamoyl]butanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid;4-Oxazolidinecarboxylic acid, 3-[(2S)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1,5-dioxo-5-[(triphenylmethyl)amino]pentyl]-2,2-dimethyl-, (4S)-
- 中文名:
- FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH
- 中文别名:
- (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-氧代-5-(三苯甲基氨基)戊酰基)-2,2-二甲基恶唑烷-4-羧酸
- CBNumber:
- CB5328372
- 分子式:
- C45H43N3O7
- 分子量:
- 737.84
- MOL File:
- Mol file
|
|
|
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH化学性质
-
沸点:
-
974.6±65.0 °C(Predicted)
-
|
-
密度:
-
1.266±0.06 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at +2°C to +8°C.
-
|
-
酸度系数(pKa):
-
3.09±0.40(Predicted)
-
|
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH性质、用途与生产工艺
Fmoc-Gln(Trt)-Ser(psi(Me,Me)pro)-OH 是一种二肽。
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH
上下游产品信息
上游原料
下游产品
FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH
生产厂家
1821378-64-6, FMOC-GLN(TRT)-SER(PSI(ME,ME)PRO)-OH 相关搜索:
(BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2-二甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 (4S)-3-[(2S)-2-[[(9H-芴-9-甲氧基)羰基]氨基]-1-氧代丙基]-2,2-二甲基-4-恶唑烷羧酸 (4S)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2-二甲基-4-恶唑烷羧酸 (5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,4-二氧代-4-[(三苯基甲基)氨基]丁基]-2,2,5-三甲基-4-恶唑烷羧酸 (BETAS,4S)-4-羧基-BETA-[[芴甲氧羰基]氨基]-2,2,5-三甲基-GAMMA-氧代-3-恶唑烷丁酸叔丁酯 (4S,5R)-3-[(2S)-2-[[芴甲氧羰基]氨基]-1,5-二氧代-5-[(三苯基甲基)氨基]戊基]-2,2,5-三甲基-4-恶唑烷羧酸 (GAMMAS,4S)-4-羧基-GAMMA-[[芴甲氧羰基]氨基]-2,2-二甲基-DELTA-氧代-3-恶唑烷戊酸叔丁酯
- peptide
- 多肽合成氨基酸原料
- 多肽片段-二肽
- 氨基酸
- (S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-5-氧代-5-(三苯甲基氨基)戊酰基)-2,2-二甲基恶唑烷-4-羧酸
- 1821378-64-6
- Fmoc-GIn(Trt)-Ser[PSI(Me,Me)Pro]-OH
- (S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-oxo-5-(tritylamino)pentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid
- 4-Oxazolidinecarboxylic acid, 3-[(2S)-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1,5-dioxo-5-[(triphenylmethyl)amino]pentyl]-2,2-dimethyl-, (4S)-
- (4S)-3-[(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-4-[(triphenylmethyl)carbamoyl]butanoyl]-2,2-dimethyl-1,3-oxazolidine-4-carboxylic acid
- FMOC-GLN(TRT)-SER(PSIME,MEPRO)-OH_1821378-64-6
- Fmoc-Gln(Trt)-Ser(ψMe,Me Pro)-OH
- (9H-Fluoren-9-yl)MethOxy]Carbonyl Gln(Trt)-SerPsi(Me, Me)Pro-OH
- FMOC-GLN(TRT)-SER(PSI-ME,MEPRO)-OH